CIK: 0001388551 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $9,853 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RZLT | REZOLUTE INC | 1,603,986 | $7,154 | 72.6% | $8.49 | -56.3% | COM NEW | 76200L309 |
| GLD | SPDR GOLD TR | 4,952 | $1,510 | 15.3% | $289.60 | — | GOLD SHS | 78463V107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 632 | $307 | 3.1% | $399.33 | +27.2% | CL B NEW | 084670702 |
| ELVN | ENLIVEN THERAPEUTICS INC | 13,097 | $263 | 2.7% | $18.93 | 0.0% | COM | 29337E102 |
| — | MIND MEDICINE MINDMED INC | 34,073 | $221 | 2.2% | $8.91 | — | COM NEW | 60255C885 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $113 | 1.1% | $3.23 | -36.2% | COM | 20454B104 |
| BCAX | BICARA THERAPEUTICS INC | 10,941 | $102 | 1.0% | $25.50 | -53.3% | COM | 055477103 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $71 | 0.7% | $23.94 | -89.7% | COM | 501976104 |
| LXEO | LEXEO THERAPEUTICS INC | 17,332 | $70 | 0.7% | $13.31 | -75.3% | COM | 52886X107 |
| IKT | INHIBIKASE THERAPEUTICS INC | 16,393 | $32 | 0.3% | $2.49 | -21.5% | COM NEW | 45719W205 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $12 | 0.1% | $1.72 | -58.3% | COM | 21077P108 |